Study sheds light on connections between type 2 diabetes, Alzheimer’s diseaseMay 12th, 2009 - 5:33 pm ICT by ANI
Washington, May 12 (ANI): While there is some evidence that the causes underlying Alzheimer’s disease (AD) and type 2 diabetes (T2D) are linked, an analysis of past studies sheds some light on this connection.
Scientists have identified several common denominators of AD and T2D, including impaired glucose/energy metabolism, altered insulin-signalling pathways, mitochondrial dysfunction, oxidative stress, and inflammation.
In one study, Daniel Kopf and Lutz Frolich reviewed 14 studies that examined the risk of incident Alzheimer’s disease in diabetic patients, and found that the risk ratios were greater than one with four studies showing statistically significant excess risk.
Another study involving almost 200 subjects with either mild cognitive impairment (MCI) or with AD, lead researchers Pablo Toro, Peter Schonknecht, and Johannes Schroder found an increased tendency for type 2 diabetes.
Paula I. Moreira and colleagues Ana I. Duarte, Maria S. Santos, A. Cristina Rego, and Catarina R. Oliveira focussed on the role of oxidative stresses and the development of AD.
They identified the processes underlying the pathogenesis of Alzheimer’s disease, including impaired glucose/energy metabolism, mitochondrial dysfunction, oxidative stress and altered insulin-signaling pathways.
Another study led by V. Prakash Reddy revealed how oxidative stress plays a major role in diabetes, Alzheimer’s disease, and other related neurological diseases.
The study has shown that advanced glycation end products and lipid peroxidation products are ubiquitous to diabetes and Alzheimer’s disease, and serve as markers of disease progression in both disorders.
Allan Jones, Philipp Kulozik, Anke Ostertag, and Stephan Herzig reviewed common metabolic and inflammatory processes implicated in the pathogenesis of both T2D and AD in their study.
They emphasized on the role of critical transcriptional checkpoints in the control of cellular metabolism, insulin sensitivity, and inflammation. The researchers hope that these transcriptional regulators might hold great promise as new therapeutic targets in the potentially combined treatment of type 2 diabetes and Alzheimer’s disease.
The findings appear in Journal of Alzheimer’s Disease. (ANI)
- Brain insulin plays critical role in development of diabetes - Feb 17, 2011
- Molecular 'switch' that contributes to cellular aging process identified - Dec 01, 2010
- Protein that modulates metabolic dysfunction in obesity identified - Jun 18, 2010
- Insulin could play powerful role in fighting Alzheimer's - Apr 02, 2011
- Potential new target for diabetes treatment identified - Nov 03, 2010
- Scientists provide genetic evidence that antioxidants can help treat cancer - Feb 16, 2011
- Human enzyme holds promise of weight loss - Nov 15, 2011
- Unhealthy diet raises heart risk for obese teens - Mar 23, 2011
- Insulin may protect patients from fatal bacterial infections - Sep 09, 2010
- Indications of Alzheimer's may be evident decades before first signs - Mar 29, 2011
- Caffeine contributes to development, poor control of diabetes? - Apr 08, 2011
- Potential new non-insulin treatment for type 1 diabetes found - Mar 25, 2011
- Insulin found promising in treating Alzheimer's - Apr 03, 2011
- Cellular mechanism behind chronic inflammation, type 2 diabetes identified - Dec 22, 2010
- Insulin resistance, type 2 diabetes linked to Alzheimer's - Aug 26, 2010
Tags: common denominators, daniel kopf, diabetic patients, disease progression, energy metabolism, excess risk, frolich, greater than one, inflammatory processes, lipid peroxidation, mild cognitive impairment, mild cognitive impairment mci, neurological diseases, ostertag, oxidative stress, rego, risk ratios, schroder, signaling pathways, type 2 diabetes